Check out InfiCures poster from the EASL 2022 meeting!
InfiCure Bio presented the poster "NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic inflammation and fibrosis (NIF) mouse model". You will find the poster here.
Visit InfiCure Poster at EASL in June 22-26!
InfiCure Bio will attend the yearly EASL meeting with a poster, please take the opportunity to check out poster #FRI-154 "NKT cells promote both type 1 and type 2 inflammatory responses in the non-obese diabetic [...]
InfiCure Bio at Umeå Life Science Job Fair!
Today on May 3rd, Umeå Biotech Incubator (UBI) organized the first Umeå Life Science Job Fair. We at InfiCure Bio were happy to get the opportunity to present our business to life science students and [...]
Pressrelease published on the CymaBay Seladelpar study!
Take the opportunity to read the pressrelease on the CymaBay study with Seladelpar in the NIF mouse. Ed Cable, sr. Director of Research at CymaBay Therapeutics, gives his view on why CymaBay chose to work [...]
Check out CymaBay Therapeutics poster on the NIF mouse at AASLD!
We are very happy that CymaBay Therapeutics chose to present the convincing data from their study in the NIF mouse. They nicely show that Seladelpar, which is a substance in clinical studies, reduces fibrosis in [...]